The adult patient with eisenmenger syndrome: A medical update after dana point part I: Epidemiology, clinical aspects and diagnostic options

Current Cardiology Reviews

Volumn 6, Issue 4, 2010, Pages 343-355

  Kaemmerer, Harald ^a   Mebus, Siegrun ^a   Schulze Neick, Ingram ^b   Eicken, Andreas ^a   Trindade, Pedro T ^c   Hager, Alfred ^a   Oechslin, Erwin ^d   Niwa, Koichiro ^e   Lang, Irene ^f   Hess, John ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d TORONTO GENERAL HOSPITAL   (Canada)

^e CHIBA CARDIOVASCULAR CENTER   (Japan)

^f UNIVERSITY OF VIENNA   (Austria)

Author keywords

Adult congenital heart defects; Cardiovascular diseases; Competence Network for Congenital Heart Defects; Eisenmenger syndrome; Followup studies; Pulmonary hypertension

Indexed keywords

ADULT; ARTICLE; CARDIOPULMONARY EXERCISE TEST; DISEASE CLASSIFICATION; EISENMENGER COMPLEX; ELECTROCARDIOGRAM; HEART CATHETERIZATION; HEART HEMODYNAMICS; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTEMIC PULMONARY SHUNT; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 78651338106     PISSN: 1573403X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340310793566154     Document Type: Article

References (69)

1. Simonneau G, Galie N, Rubin LJ, et al. Clinical classification ofpulmonary hypertension. J Am Coll Cardiol 2004; 43(12 Suppl S): 5S-12S.
2. Galie N, Hoeper MM, Humbert M, et al. Guidelines for thediagnosis and treatment of pulmonary hypertension: The TaskForce for the Diagnosis and Treatment of Pulmonary Hypertensionof the European Society of Cardiology (ESC) and the EuropeanRespiratory Society (ERS), endorsed by the International Societyof Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30(20): 2493-537.
3. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinicalclassification of pulmonary hypertension. J Am Coll Cardiol 2009; 54(1 Suppl): S43-54.
4. Badesch DB, Champion HC, Sanchez MA, et al. Diagnosis andassessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54(1 Suppl): S55-66.
5. Eisenmenger V. Die angeborenen Defecte der Kammerscheidewanddes Herzens. Z Klin Med 1897; 32: 1-28.
6. Partin C. The evolution of Eisenmenger's eponymic enshrinement. Am J Cardiol 2003; 92(10): 1187-91.
7. Wood P. The Eisenmenger syndrome or pulmonary hypertensionwith reversed central shunt. I. Br Med J 1958; 2(5098): 701-9.
8. Budts W, Van Pelt N, Gillyns H, Gewillig M, Van De Werf F, Janssens S. Residual pulmonary vasoreactivity to inhaled nitricoxide in patients with severe obstructive pulmonary hypertensionand Eisenmenger syndrome. Heart 2001; 86(5): 553-8.
9. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonaryarterial hypertension. N Engl J Med 2004; 351(14): 1425-36.
10. Young D, Mark H. Fate of the patient with the Eisenmengersyndrome. Am J Cardiol 1971; 28(6): 658-69.
11. Duffels MG, Engelfriet PM, Berger RM, et al. Pulmonary arterialhypertension in congenital heart disease: an epidemiologicperspective from a Dutch registry. Int J Cardiol 2007; 120(2): 198-204.
12. Hopkins WE, Ochoa LL, Richardson GW, Trulock EP. Comparisonof the hemodynamics and survival of adults with severeprimary pulmonary hypertension or Eisenmenger syndrome. JHeart Lung Transplant 1996; 15(1 Pt 1): 100-5.
13. Hopkins WE. The remarkable right ventricle of patients withEisenmenger syndrome. Coron Artery Dis 2005; 16(1): 19-25.
14. Hopkins WE, Waggoner AD. Severe pulmonary hypertensionwithout right ventricular failure: the unique hearts of patients withEisenmenger syndrome. Am J Cardiol 2002; 89(1): 34-8.
15. Kidd L, Driscoll DJ, Gersony WM, et al. Second natural historystudy of congenital heart defects. Results of treatment of patientswith ventricular septal defects. Circulation 1993; 87(2 Suppl): I38-51.
16. Saha A, Balakrishnan KG, Jaiswal PK, et al. Prognosis for patientswith Eisenmenger syndrome of various aetiology. Int J Cardiol 1994; 45(3): 199-207.
17. Vongpatanasin W, Brickner ME, Hillis LD, Lange RA. TheEisenmenger syndrome in adults. Ann Intern Med 1998; 128(9): 745-55.
18. Celermajer DS, Cullen S, Deanfield JE. Impairment of endothelium-dependent pulmonary artery relaxation in children withcongenital heart disease and abnormal pulmonary hemodynamics. Circulation 1993; 87(2): 440-6.
19. Rabinovitch M. Elastase and the pathobiology of unexplainedpulmonary hypertension. Chest 1998; 114(3 Suppl): 213S-24S.
20. Yoshibayashi M, Nishioka K, Nakao K, et al. Plasma endothelinconcentrations in patients with pulmonary hypertension associatedwith congenital heart defects. Evidence for increased production ofendothelin in pulmonary circulation. Circulation 1991; 84(6): 2280-5.
21. Fuse S, Kamiya T. Plasma thromboxane B2 concentration inpulmonary hypertension associated with congenital heart disease. Circulation 1994; 90(6): 2952-5.
22. Hassoun PM, Mouthon L, Barbera JA, et al. Inflammation, growthfactors, and pulmonary vascular remodeling. J Am Coll Cardiol 2009; 54(1 Suppl): S10-9.
23. Galie N, Manes A, Palazzini M, et al. Management of pulmonaryarterial hypertension associated with congenital systemic-topulmonaryshunts and Eisenmenger's syndrome. Drugs 2008; 68(8): 1049-66.
24. Kaemmerer H, Fratz S, Braun SL, et al. Erythrocyte indexes, ironmetabolism, and hyperhomocysteinemia in adults with cyanoticcongenital cardiac disease. Am J Cardiol 2004; 94(6): 825-8.
25. Yock PG, Popp RL. Noninvasive estimation of right ventricularsystolic pressure by Doppler ultrasound in patients with tricuspidregurgitation. Circulation 1984; 70(4): 657-62.
26. Kircher BJ, Himelman RB, Schiller NB. Noninvasive estimation ofright atrial pressure from the inspiratory collapse of the inferiorvena cava. Am J Cardiol 1990; 66(4): 493-6.
27. Masuyama T, Kodama K, Kitabatake A, Sato H, Nanto S, Inoue M. Continuous-wave Doppler echocardiographic detection ofpulmonary regurgitation and its application to noninvasiveestimation of pulmonary artery pressure. Circulation 1986; 74(3): 484-92.
28. Lang RM, Bierig M, Devereux RB, et al. Recommendations forchamber quantification: a report from the American Society ofEchocardiography's Guidelines and Standards Committee and theChamber Quantification Writing Group, developed in conjunctionwith the European Association of Echocardiography, a branch ofthe European Society of Cardiology. J Am Soc Echocardiogr 2005; 18(12): 1440-63.
29. Yang HS, Bansal RC, Mookadam F, Khandheria BK, Tajik AJ, Chandrasekaran K. Practical guide for three-dimensional transthoracicechocardiography using a fully sampled matrix arraytransducer. J Am Soc Echocardiogr 2008; 21(9): 979-89; quiz1081-2.
30. Klein AL, Grimm RA, Murray RD, et al. Use of transesophagealechocardiography to guide cardioversion in patients with atrialfibrillation. N Engl J Med 2001; 344(19): 1411-20.
31. Shively BK, Gurule FT, Roldan CA, Leggett JH, Schiller NB. Diagnostic value of transesophageal compared with transthoracicechocardiography in infective endocarditis. J Am Coll Cardiol 1991; 18(2): 391-7.
32. Babu-Narayan SV, Gatzoulis MA, Kilner PJ. Non-invasiveimaging in adult congenital heart disease using cardiovascularmagnetic resonance. J Cardiovasc Med (Hagerstown) 2007; 8(1): 23-9.
33. Maceira AM, Prasad SK, Khan M, Pennell DJ. Reference rightventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precessioncardiovascular magnetic resonance. Eur Heart J 2006; 27(23): 2879-88.
34. Wilkins MR, Paul GA, Strange JW, et al. Sildenafil versusEndothelin Receptor Antagonist for Pulmonary Hypertension(SERAPH) study. Am J Respir Crit Care Med 2005; 171(11): 1292-7.
35. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on thediagnosis and management of acute pulmonary embolism: the TaskForce for the Diagnosis and Management of Acute PulmonaryEmbolism of the European Society of Cardiology (ESC). Eur HeartJ 2008; 29(18): 2276-315.
36. Perloff JK, Hart EM, Greaves SM, Miner PD, Child JS. Proximalpulmonary arterial and intrapulmonary radiologic features ofEisenmenger syndrome and primary pulmonary hypertension. AmJ Cardiol 2003; 92(2): 182-7.
37. Silversides CK, Granton JT, Konen E, Hart MA, Webb GD, Therrien J. Pulmonary thrombosis in adults with Eisenmengersyndrome. J Am Coll Cardiol 2003; 42(11): 1982-7.
38. Von Euler U, Liljistrand G. Observation on the pulmonary arterialblood pressure in the cat. Acta Physiol Scand 1946; 12: 3001-320.
39. Verges S, Flore P, Favre-Juvin A, Levy P, Wuyam B. Exhalednitric oxide during normoxic and hypoxic exercise in enduranceathletes. Acta Physiol Scand 2005; 185(2): 123-31.
40. Oelberg DA, Marcotte F, Kreisman H, Wolkove N, Langleben D, Small D. Evaluation of right ventricular systolic pressure duringincremental exercise by Doppler echocardiography in adults withatrial septal defect. Chest 1998; 113(6): 1459-65.
41. Bossone E, Rubenfire M, Bach DS, Ricciardi M, Armstrong WF. Range of tricuspid regurgitation velocity at rest and during exercisein normal adult men: implications for the diagnosis of pulmonaryhypertension. J Am Coll Cardiol 1999; 33(6): 1662-6.
42. Groves BM, Reeves JT, Sutton JR, et al. Operation Everest II:elevated high-altitude pulmonary resistance unresponsive tooxygen. J Appl Physiol 1987; 63(2): 521-30.
43. Galie N, Torbicki A, Barst R, et al. Guidelines on diagnosis andtreatment of pulmonary arterial hypertension. The Task Force onDiagnosis and Treatment of Pulmonary Arterial Hypertension ofthe European Society of Cardiology. Eur Heart J 2004; 25(24): 2243-78.
44. Grunig E, Janssen B, Mereles D, et al. Abnormal pulmonary arterypressure response in asymptomatic carriers of primary pulmonaryhypertension gene. Circulation 2000; 102(10): 1145-50.
45. Ikawa S, Shimazaki Y, Nakano S, Kobayashi J, Matsuda H, Kawashima Y. Pulmonary vascular resistance during exercise lateafter repair of large ventricular septal defects. Relation to age at thetime of repair. J Thorac Cardiovasc Surg 1995; 109(6): 1218-24.
46. Mocellin R. [Sports fitness in pulmonary hypertension]. Wien KlinWochenschr 1986; 98(21): 735-9.
47. Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Exercisepathophysiology in patients with primary pulmonary hypertension. Circulation 2001; 104(4): 429-35.
48. Diller GP, Dimopoulos K, Okonko D, et al. Exercise intolerance inadult congenital heart disease: comparative severity, correlates, andprognostic implication. Circulation 2005; 112(6): 828-35.
49. Yasunobu Y, Oudiz RJ, Sun XG, Hansen JE, Wasserman K. EndtidalPCO2 abnormality and exercise limitation in patients withprimary pulmonary hypertension. Chest 2005; 127(5): 1637-46.
50. Dimopoulos K, Okonko DO, Diller GP, et al. Abnormal ventilatoryresponse to exercise in adults with congenital heart disease relatesto cyanosis and predicts survival. Circulation 2006; 113(24): 2796-802.
51. Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Gas exchangedetection of exercise-induced right-to-left shunt in patients withprimary pulmonary hypertension. Circulation 2002; 105(1): 54-60.
52. Daliento L, Rebellato L, Angelini A, et al. Fatal outcome inEisenmenger syndrome. Cardiovasc Pathol 2002; 11(4): 221-8.
53. Daliento L, Somerville J, Presbitero P, et al. Eisenmengersyndrome. Factors relating to deterioration and death. Eur Heart J 1998; 19(12): 1845-55.
54. Hirth A, Reybrouck T, Bjarnason-Wehrens B, Lawrenz W, Hoffmann A. Recommendations for participation in competitive andleisure sports in patients with congenital heart disease: a consensusdocument. Eur J Cardiovasc Prev Rehabil 2006; 13(3): 293-9.
55. Newman JH, Sinclair-Smith BC. Risk of high-altitude travel in apatient with Eisenmenger's syndrome. South Med J 1984; 77(8): 1057-8.
56. Broberg CS, Uebing A, Cuomo L, Thein SL, Papadopoulos MG, Gatzoulis MA. Adult patients with Eisenmenger syndrome reportflying safely on commercial airlines. Heart 2007; 93(12): 1599-603.
57. Hambrecht R, Fiehn E, Weigl C, et al. Regular physical exercisecorrects endothelial dysfunction and improves exercise capacity inpatients with chronic heart failure. Circulation 1998; 98(24): 2709-15.
58. Piepoli MF, Davos C, Francis DP, Coats AJ. Exercise trainingmeta-analysis of trials in patients with chronic heart failure(ExTraMATCH). BMJ 2004; 328(7433): 189.
59. Goret L, Reboul C, Tanguy S, Dauzat M, Obert P. Training doesnot affect the alteration in pulmonary artery vasoreactivity inpulmonary hypertensive rats. Eur J Pharmacol 2005; 527(1-3): 121-8.
60. Mereles D, Ehlken N, Kreuscher S, et al. Exercise and respiratorytraining improve exercise capacity and quality of life in patientswith severe chronic pulmonary hypertension. Circulation 2006; 114(14): 1482-9.
61. Newman JH, Robbins IM. Exercise training in pulmonaryhypertension: implications for the evaluation of drug trials. Circulation 2006; 114(14): 1448-9.
62. Vargo T. Cardiac catheterization: Hemodynamic measurements. The science and practise of pediatric cardiology: Williams&Wilkins; 2005.
63. Lock JK, Perry S. Diagnostic and interventional catheterization incongenital heart disease. 2nd edition ed. Boston/Dordrecht/London:Kluwer Academic Publishers; 2000.
64. LaFarge CG, Miettinen OS. The estimation of oxygenconsumption. Cardiovasc Res 1970; 4(1): 23-30.
65. Bernhart FS. The iron content of crystalline human hemoglobin. JBiol Chem 1943; 147: 19-22.
66. Van Slyke DN. The determinantion of gases in blood and othersolutions by vacuum extraction and manometric measurements. JBiol Chem 1924; 61: 523-73.
67. Wood P. Special investigations. 2nd ed. Philadelphia: JBLippincott; 1956.
68. Jarmakani J. Catheterization and angiography. 3rd ed. Baltimore:Williams&Wilkins; 1983.
69. Eicken A, Balling G, Gildein HP, Genz T, Kaemmerer H, Hess J. Transcatheter closure of a non-restrictive patent ductus arteriosuswith an Amplatzer muscular ventricular septal defect occluder. IntJ Cardiol 2007; 117(1): e40-2.